183 related articles for article (PubMed ID: 14504844)
1. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
[TBL] [Abstract][Full Text] [Related]
2. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
[TBL] [Abstract][Full Text] [Related]
4. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
Parmar H; Sitoh YY; Ho L
J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
[TBL] [Abstract][Full Text] [Related]
5. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
[TBL] [Abstract][Full Text] [Related]
6. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
[TBL] [Abstract][Full Text] [Related]
7. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
[No Abstract] [Full Text] [Related]
9. Computed tomography findings in maple syrup urine disease.
Ong LC; Khoo TB; Zulfiqar A; Zarida H; Ruzana A
Singapore Med J; 1998 Aug; 39(8):370-2. PubMed ID: 9844500
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
[TBL] [Abstract][Full Text] [Related]
11. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal diffusion-weighted imaging in infants with hydrocephalus: decrease in tissue water diffusion after cerebrospinal fluid diversion.
Leliefeld PH; Gooskens RH; Braun KP; Ramos LM; Uiterwaal CS; Regli LP; Tulleken CA; Kappelle LJ; Hanlo PW
J Neurosurg Pediatr; 2009 Jul; 4(1):56-63. PubMed ID: 19569912
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.
Brismar J; Aqeel A; Brismar G; Coates R; Gascon G; Ozand P
AJNR Am J Neuroradiol; 1990; 11(6):1219-28. PubMed ID: 2124065
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
[TBL] [Abstract][Full Text] [Related]
15. The electroencephalogram in neonatal maple syrup urine disease: a case report.
Agadi S; Sutton VR; Quach MM; Riviello JJ
Clin EEG Neurosci; 2012 Jan; 43(1):64-7. PubMed ID: 22423553
[TBL] [Abstract][Full Text] [Related]
16. Diffusion changes suggesting predominant vasogenic oedema during partial status epilepticus.
Hong KS; Cho YJ; Lee SK; Jeong SW; Kim WK; Oh EJ
Seizure; 2004 Jul; 13(5):317-21. PubMed ID: 15158702
[TBL] [Abstract][Full Text] [Related]
17. Changes in the auditory nerve brainstem evoked responses in a case of maple syrup urine disease.
Geal-Dor M; Adelman C; Levi H; Goitein K; Sohmer H
Dev Med Child Neurol; 2004 Mar; 46(3):184-6. PubMed ID: 14995088
[TBL] [Abstract][Full Text] [Related]
18. Neonatal maple syrup urine disease case report and literature review.
Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
[TBL] [Abstract][Full Text] [Related]
19. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; OĊtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
20. Teaching NeuroImages: MRI in maple syrup urine disease.
Bindu PS; Kovoor JM; Christopher R
Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
